Waist-hip ratio is superior to BMI in predicting liver-related outcomes and synergizes with harmful alcohol use.


Journal

Communications medicine
ISSN: 2730-664X
Titre abrégé: Commun Med (Lond)
Pays: England
ID NLM: 9918250414506676

Informations de publication

Date de publication:
06 Sep 2023
Historique:
received: 05 02 2023
accepted: 31 08 2023
medline: 7 9 2023
pubmed: 7 9 2023
entrez: 6 9 2023
Statut: epublish

Résumé

Obesity is associated with liver disease, but the best obesity-related predictor remains undefined. Controversy exists regarding possible synergism between obesity and alcohol use for liver-related outcomes (LRO). We assessed the predictive performance for LROs, and synergism with alcohol use, of abdominal obesity (waist-hip ratio, WHR), and compared it to overall obesity (body mass index, BMI). Forty-thousand nine-hundred twenty-two adults attending the Finnish health-examination surveys, FINRISK 1992-2012 and Health 2000 studies, were followed through linkage with electronic healthcare registries for LROs (hospitalizations, cancers, and deaths). Predictive performance of obesity measures (WHR, waist circumference [WC], and BMI) were assessed by Fine-Gray models and time-dependent area-under-the-curve (AUC). There are 355 LROs during a median follow-up of 12.9 years (509047.8 person-years). WHR and WC emerge as more powerful predictors of LROs than BMI. WHR shows significantly better 10-year AUC values for LROs (0.714, 95% CI 0.685-0.743) than WC (0.648, 95% CI 0.617-0.679) or BMI (0.550, 95% CI 0.514-0.585) both overall and separately among men and women. WHR is predictive also in BMI strata. Absolute 10-year risks of LROs are more dependent on WHR than BMI. Moreover, WHR shows a significant supra-additive interaction effect with harmful alcohol use for liver-related outcomes (excess 10-year cumulative incidence of 2.8% from the interaction), which is not seen between BMI and harmful alcohol use. WHR is a better predictor than BMI or WC for LROs, and WHR better reflects the synergism with harmful alcohol use. WHR should be included in clinical assessment when evaluating obesity-related risks for liver outcomes. Obesity has been linked to liver disease, but the most accurate measure for predicting obesity-related liver disease outcomes remains uncertain. In this study, we analyzed data from over 40,000 adults to compare the extent to which different measures of obesity can predict liver-related outcomes, such as severe liver disease, liver failure, or death from liver disease. The measures of obesity were the ratio of waist circumference to hip circumference (waist-hip ratio, WHR), waist circumference (WC), and body mass index (BMI). Our findings reveal that WHR and WC are stronger predictors of these outcomes than BMI. In particular, WHR demonstrated superior predictive ability and this predictive ability was influenced by harmful alcohol use. This study suggests that WHR may be a relatively simple but useful measure for clinicians to use when predicting obesity-related risks for liver health.

Sections du résumé

BACKGROUND BACKGROUND
Obesity is associated with liver disease, but the best obesity-related predictor remains undefined. Controversy exists regarding possible synergism between obesity and alcohol use for liver-related outcomes (LRO). We assessed the predictive performance for LROs, and synergism with alcohol use, of abdominal obesity (waist-hip ratio, WHR), and compared it to overall obesity (body mass index, BMI).
METHODS METHODS
Forty-thousand nine-hundred twenty-two adults attending the Finnish health-examination surveys, FINRISK 1992-2012 and Health 2000 studies, were followed through linkage with electronic healthcare registries for LROs (hospitalizations, cancers, and deaths). Predictive performance of obesity measures (WHR, waist circumference [WC], and BMI) were assessed by Fine-Gray models and time-dependent area-under-the-curve (AUC).
RESULTS RESULTS
There are 355 LROs during a median follow-up of 12.9 years (509047.8 person-years). WHR and WC emerge as more powerful predictors of LROs than BMI. WHR shows significantly better 10-year AUC values for LROs (0.714, 95% CI 0.685-0.743) than WC (0.648, 95% CI 0.617-0.679) or BMI (0.550, 95% CI 0.514-0.585) both overall and separately among men and women. WHR is predictive also in BMI strata. Absolute 10-year risks of LROs are more dependent on WHR than BMI. Moreover, WHR shows a significant supra-additive interaction effect with harmful alcohol use for liver-related outcomes (excess 10-year cumulative incidence of 2.8% from the interaction), which is not seen between BMI and harmful alcohol use.
CONCLUSIONS CONCLUSIONS
WHR is a better predictor than BMI or WC for LROs, and WHR better reflects the synergism with harmful alcohol use. WHR should be included in clinical assessment when evaluating obesity-related risks for liver outcomes.
Obesity has been linked to liver disease, but the most accurate measure for predicting obesity-related liver disease outcomes remains uncertain. In this study, we analyzed data from over 40,000 adults to compare the extent to which different measures of obesity can predict liver-related outcomes, such as severe liver disease, liver failure, or death from liver disease. The measures of obesity were the ratio of waist circumference to hip circumference (waist-hip ratio, WHR), waist circumference (WC), and body mass index (BMI). Our findings reveal that WHR and WC are stronger predictors of these outcomes than BMI. In particular, WHR demonstrated superior predictive ability and this predictive ability was influenced by harmful alcohol use. This study suggests that WHR may be a relatively simple but useful measure for clinicians to use when predicting obesity-related risks for liver health.

Autres résumés

Type: plain-language-summary (eng)
Obesity has been linked to liver disease, but the most accurate measure for predicting obesity-related liver disease outcomes remains uncertain. In this study, we analyzed data from over 40,000 adults to compare the extent to which different measures of obesity can predict liver-related outcomes, such as severe liver disease, liver failure, or death from liver disease. The measures of obesity were the ratio of waist circumference to hip circumference (waist-hip ratio, WHR), waist circumference (WC), and body mass index (BMI). Our findings reveal that WHR and WC are stronger predictors of these outcomes than BMI. In particular, WHR demonstrated superior predictive ability and this predictive ability was influenced by harmful alcohol use. This study suggests that WHR may be a relatively simple but useful measure for clinicians to use when predicting obesity-related risks for liver health.

Identifiants

pubmed: 37674006
doi: 10.1038/s43856-023-00353-2
pii: 10.1038/s43856-023-00353-2
pmc: PMC10482890
doi:

Types de publication

Journal Article

Langues

eng

Pagination

119

Subventions

Organisme : Academy of Finland (Suomen Akatemia)
ID : 338544

Informations de copyright

© 2023. Springer Nature Limited.

Références

Gut. 2018 Aug;67(8):1536-1542
pubmed: 28320770
Liver Int. 2021 Dec;41(12):2903-2913
pubmed: 34510711
JHEP Rep. 2021 Jun 29;3(5):100325
pubmed: 34401690
Clin Gastroenterol Hepatol. 2017 Aug;15(8):1294-1301.e2
pubmed: 28342948
Alcohol Clin Exp Res. 2020 Feb;44(2):384-403
pubmed: 31854001
Hepatology. 2022 Feb;75(2):369-378
pubmed: 34453350
Hepatol Commun. 2021 Mar 08;5(6):1021-1035
pubmed: 34141987
BMJ. 2010 Mar 11;340:c912
pubmed: 20223875
J Am Diet Assoc. 1997 May;97(5):534-6
pubmed: 9145094
Liver Int. 2017 Sep;37(9):1373-1381
pubmed: 28276137
Sensors (Basel). 2020 Oct 29;20(21):
pubmed: 33138133
J Hepatol. 2022 Sep;77(3):887-889
pubmed: 35460724
Hepatology. 2021 Jul;74(1):474-482
pubmed: 33486773
Liver Int. 2021 Jun;41(6):1216-1226
pubmed: 33283434
Am J Gastroenterol. 2019 Oct;114(10):1574-1586
pubmed: 31464740
Mol Med. 2014 Dec 10;20:490-502
pubmed: 25180626
Nat Genet. 2017 Jan;49(1):17-26
pubmed: 27841877
Scand J Gastroenterol. 2023 Feb;58(2):170-177
pubmed: 35989617
Int J Epidemiol. 2018 Jun 1;47(3):696-696i
pubmed: 29165699
BMJ. 2010 Mar 11;340:c1240
pubmed: 20223873
BMC Med Res Methodol. 2016 May 04;16:49
pubmed: 27145829
J Hepatol. 2023 Jan;78(1):191-206
pubmed: 36063967
Scand J Gastroenterol. 2018 Feb;53(2):212-217
pubmed: 29276897
J Hepatol. 2011 Sep;55(3):673-682
pubmed: 21256905
Int J Cancer. 2019 Sep 1;145(5):1245-1253
pubmed: 30665257
Gastroenterol Res Pract. 2012;2012:362147
pubmed: 22701476
Biometrics. 2015 Mar;71(1):102-113
pubmed: 25311240
J Hepatol. 2022 Aug;77(2):302-311
pubmed: 35271949
Obes Res Clin Pract. 2018 Jul - Aug;12(4):394-396
pubmed: 30078405
Lancet Diabetes Endocrinol. 2020 Jul;8(7):616-627
pubmed: 32559477
Clin Gastroenterol Hepatol. 2019 Jul;17(8):1625-1633.e1
pubmed: 30476585

Auteurs

Fredrik Åberg (F)

Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. Fredrik.Aberg@helsinki.fi.

Martti Färkkilä (M)

Abdominal Center, Helsinki University and Helsinki University Hospital, Helsinki, Finland.

Veikko Salomaa (V)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Antti Jula (A)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Satu Männistö (S)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Markus Perola (M)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Annamari Lundqvist (A)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Ville Männistö (V)

Departments of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Classifications MeSH